Cardiology experts highlighted the increase of opportunities with the field of interventional heart failure, advocating for more standardized training pathways in the subspeciality, according to a ...

WASHINGTON–Interventional heart failure (IHF) has rapidly evolved as a critical subspecialty within cardiology at the crossroads of advanced heart failure and interventional cardiology. The increasing ...

Aaron M Wolfson, MD, and Sarah J Goodlin, MD, discuss nonpharmacologic interventions for patients with heart failure. Despite significant advances in the pharmacologic management of individuals with ...

Heart failure remains a leading cause of morbidity and mortality across the globe, driven by ageing populations and rising prevalence of hypertension, ischaemic heart disease and diabetes. Therapeutic ...

SUNNYVALE, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (“BioCardia” or the “Company”) (Nasdaq: BCDA), a biotechnology company focused on advancing late-stage cell therapy interventions ...

Transitional care interventions for heart failure encompass structured processes and services designed to ensure continuity of care as patients move from hospital settings to home or community ...

TAMPA, Fla., May 9, 2025 /PRNewswire/ -- Interventional structural cardiologists at Tampa General Hospital (TGH) and USF Health have completed the first procedure in Florida under the FDA Early ...

Valvular heart disease, identified through cardiovascular imaging, is common in cancer patients. Interventions to treat valvular heart disease significantly improved survival. These findings were ...

Millions of Americans live with a hidden heart condition, and researchers have found a key, noticeable warning sign.

SUNNYVALE, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (BCDA) (“BioCardia” or the “Company”) (Nasdaq: BCDA), a biotechnology company focused on ...